Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood ...

A biologics license application for pivekimab sunirine (PVEK) has been submitted to the U.S. Food and Drug Administration ...

Pittsburgh EMS Assistant Chief Mark Pinchalk announced Friday that two city rescue units are now stocked with Type O blood. Pittsburgh’s Bureau of Emergency Medical Services is writing the script for ...

An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

A recent study by ConsumerAffairs ranked the top 25 cities have the worst drivers in the United States. Did yours make the ...

A practical look at the challenges of diagnosing and managing feline hyperthyroidism, from misleading symptoms to complex ...

BMC accused of abandoning affordable healthcare as PPP shift pushes essential treatment beyond the reach of those who need it ...

Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

South Florida oncologists are seeing an alarming rise in a hard-to-detect breast cancer that is increasing at more than ...

Clinicians and researchers continue to push back on unsupported claims about the causes of autism while new NIH projects aim ...